Smart dosing for high blood pressure in liver disease patients shows promise
NCT ID NCT07397481
First seen Feb 19, 2026 · Last updated Jun 05, 2026 · Updated 14 times
Summary
This study tested whether using a computer program to predict the right dose of blood pressure medication works better for people with liver cirrhosis. Forty participants with cirrhosis and high blood pressure received either nebivolol or carvedilol at doses suggested by the program. Researchers monitored blood pressure, liver function, and side effects over three months to see if the personalized dosing was safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kafrelsheikh University
Cairo, Egypt, Egypt
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.